Gregory D. Perry

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Waltham, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Peter Silverman as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gregory D. Perry

Form 4 holding Chief Financial Officer & PFO

Merus N.V.

Security class
Share Option (right to buy)
Shares / value
0
Estimated value
$1,450,696
Report date
12 Dec 2025
Price
$13.52
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Financial Officer

Finch Therapeutics Group, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
80,000
Estimated value
Report date
25 Feb 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

KALA BIO, Inc.

Security class
Stock Option (right to buy)
Shares / value
5,450
Estimated value
Report date
15 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Gregory D. Perry

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .